Financial reports
10-K
2023 FY
Annual report
15 Apr 24
NT 10-K
Notice of late annual filing
28 Mar 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
2 Mar 23
10-Q
2022 Q3
Quarterly report
1 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
25 Jan 22
Current reports
8-K
Departure of Directors or Certain Officers
19 Apr 24
8-K
Entry into a Material Definitive Agreement
28 Mar 24
8-K
Entry into a Material Definitive Agreement
26 Jun 23
8-K
Departure of Directors or Certain Officers
3 May 23
8-K
Entry into a Material Definitive Agreement
12 Jul 22
8-K
Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement with Case Western Reserve University
5 May 22
8-K
Entry into a Material Definitive Agreement
22 Feb 22
8-K
Mosaic ImmunoEngineering Inc. Elects Biotechnology Industry Veteran Robert A. Baffi, Ph.D. to Its Board of Directors
15 Jun 21
8-K
Entry into a Material Definitive Agreement
10 May 21
8-K
Amendments to Articles of Incorporation or Bylaws
30 Dec 20
Registration and prospectus
RW
Registration withdrawal request
28 Dec 22
S-1
IPO registration
4 Feb 22
S-8
Registration of securities for employees
9 Mar 21
S-3/A
Shelf registration (amended)
21 Jan 21
S-3
Shelf registration
10 Dec 20
D
$3.75K in options / securities to be acquired, sold $3.75K, 1 investor
26 Jan 10
S-8
Registration of securities for employees
2 Apr 09
S-8
Registration of securities for employees
28 Mar 08
POS AM
Prospectus update (post-effective amendment)
26 Dec 07
SB-2/A
Registration of securities for small business issuer (amended)
2 Apr 07
Proxies
DEF 14C
Information statement
25 Jun 21
PRE 14C
Preliminary information
15 Jun 21
DEF 14C
Information statement
2 Nov 20
PRE 14C
Preliminary information
23 Oct 20
DEF 14A
Definitive proxy
18 Apr 18
DEFA14A
Additional proxy soliciting materials
18 Apr 18
DEF 14A
Definitive proxy
15 Mar 17
DEF 14A
Definitive proxy
18 Mar 16
PRE 14A
Preliminary proxy
8 Mar 16
DEF 14A
Definitive proxy
9 Mar 15
Other
EFFECT
Notice of effectiveness
1 Feb 21
CORRESP
Correspondence with SEC
25 Jan 21
CORRESP
Correspondence with SEC
21 Jan 21
UPLOAD
Letter from SEC
21 Dec 20
CT ORDER
Confidential treatment order
26 Sep 16
CT ORDER
Confidential treatment order
5 Jan 15
CT ORDER
Confidential treatment order
16 Sep 14
CT ORDER
Confidential treatment order
14 Feb 13
NO ACT
No action letter
18 Oct 10
NO ACT
No action letter
29 Sep 10
Ownership
4
STEVEN W KING
22 Feb 22
4
GLORIA FELCYN
22 Feb 22
4
ROBERT L GARNICK
22 Feb 22
4
ROBERT BAFFI
22 Feb 22
4
Nicole Franziska Steinmetz
22 Feb 22
3
ROBERT BAFFI
16 Jul 21
4
ROBERT L GARNICK
10 May 21
4
GLORIA FELCYN
10 May 21
4
Nicole Franziska Steinmetz
30 Apr 21
4
Nicole Franziska Steinmetz
29 Jan 21